Laurent Pharmaceuticals Receives a CAD 2.7M Financing from BioMed Propulsion Fund

4 December 2019

Laurent Pharmaceuticals Inc. (the “Company”), a biopharmaceutical company focusing on rare diseases, today announced that it has received the final approval...

Read More

Laurent Pharmaceuticals Receives an Additional up to $3M Award from Cystic Fibrosis Foundation

31 October 2019

Laurent Pharmaceuticals Inc. (the “Company”), today announced that it has reached an agreement to receive an additional funding of up to US$ 3 million...

Read More


Laurent Pharma to participate to H.C. Wainwright 23rd Annual Global Investment Conference, September 13-15, 2021